Showing 1381-1400 of 8668 for: Cochrane Systematic Reviews Back
- Chemotherapy alone versus chemotherapy plus radiotherapy for adults with early stage Hodgkin lymphoma
Cochrane Systematic Reviews, 27-Apr-2017
Combined modality treatment consisting of chemotherapy followed by localised radiotherapy is the standard treatment for patients with early stage Hodgkin lymphoma (HL). However, due to long- term adverse effects such as secondary malignancies the role of
- Chemotherapy alone versus endocrine therapy alone for metastatic breast cancer
Cochrane Systematic Reviews, 22-Apr-2003
Both chemotherapy and endocrine therapy can be used as treatments for metastatic breast cancer.
- Chemotherapy and radiotherapy for advanced pancreatic cancer
Cochrane Systematic Reviews, 11-Mar-2018
Pancreatic cancer (PC) is a highly lethal disease with few effective treatment options. Over the past few decades, many anti-cancer therapies have been tested in the locally advanced and metastatic setting, with mixed results. This review attempts to synt
- Chemotherapy and radiotherapy for inoperable advanced pancreatic cancer
Cochrane Systematic Reviews, 5-Aug-2009
Pancreatic cancer has a poor prognosis. The benefit of chemotherapy, radiotherapy or both as a palliative treatment of advanced or relapsed disease is uncertain.
- Chemotherapy and supportive care versus supportive care alone for advanced non-small cell lung cancer
Cochrane Systematic Reviews, 12-Sep-2012
Since our individual patient data (IPD) meta-analysis of supportive care and chemotherapy for non-small cell lung cancer (NSCLC), published in 1995, many trials have been completed. We have carried out an updated IPD meta-analysis to assess newer regimens
- Chemotherapy and surgery versus surgery alone in non-small cell lung cancer
Cochrane Systematic Reviews, 17-Sep-2008
The role of pre-operative chemotherapy in the treatment of patients with non-small cell lung cancer (NSCLC) was not clear. A systematic review and quantitative meta-analysis were therefore undertaken to evaluate the available evidence from randomised tria
- Chemotherapy and/or radiotherapy in combination with surgery for ovarian carcinosarcoma
Cochrane Systematic Reviews, 28-Feb-2013
Ovarian carcinosarcoma, also known as malignant mixed Mullerian tumour, is a rare malignant gynaecological tumour constituting about 1% or less of all ovarian cancers. In over 80% of cases, there is extra-ovarian intra-abdominal spread at diagnosis. The p
- Chemotherapy as an adjunct to radiotherapy in locally advanced nasopharyngeal carcinoma
Cochrane Systematic Reviews, 27-Apr-2015
A previous meta-analysis investigated the role of chemotherapy in head and neck locally advanced carcinoma. This work had not been performed on nasopharyngeal carcinoma.
- Chemotherapy for advanced gastric cancer
Cochrane Systematic Reviews, 25-Aug-2017
Gastric cancer is the fifth most common cancer worldwide. In "Western" countries, most people are either diagnosed at an advanced stage, or develop a relapse after surgery with curative intent. In people with advanced disease, significant benefits from ta
- Chemotherapy for advanced non‐small cell lung cancer in the elderly population
Cochrane Systematic Reviews, 20-Oct-2015
Approximately 50% of patients with newly diagnosed non-small cell lung cancer (NSCLC) are over 70 years of age at diagnosis. Despite this fact, these patients are underrepresented in randomized controlled trials (RCTs). As a consequence, the most appropri
- Chemotherapy for advanced ovarian cancer
Cochrane Systematic Reviews, 25-Jan-1999
Ovarian carcinoma is the seventh commonest female cancer worldwide and is responsible for the greatest number of deaths from gynaecological malignancy in Europe and North America. Although many studies have explored the use of chemotherapy in this disease
- Chemotherapy for advanced, recurrent or metastatic endometrial carcinoma
Cochrane Systematic Reviews, 15-Aug-2012
Although endometrial adenocarcinoma is a common gynaecological cancer, a comparatively small proportion of patients present with, or develop, recurrent or advanced disease. However, for those women whose disease does progress or recur the prognosis is poo
- Chemotherapy for brain metastases from small cell lung cancer
Cochrane Systematic Reviews, 11-May-2012
Small cell lung cancer (SCLC) accounts for approximately 20% of all cases of lung cancer. It tends to disseminate early in the course of its natural history and to grow quickly. Approximately 10% to 18% of patients present with brain metastases (BM) at th
- Chemotherapy for children with medulloblastoma
Cochrane Systematic Reviews, 18-Dec-2014
Post-surgical radiotherapy (RT) in combination with chemotherapy is considered as standard of care for medulloblastoma in children. Chemotherapy has been introduced to improve survival and to reduce RT-induced adverse effects. Reduction of RT-induced adve
- Chemotherapy for high‐grade glioma
Cochrane Systematic Reviews, 21-Oct-2002
Trials on the effect of systemic chemotherapy on survival and recurrence in adults with high-grade glioma have had inconclusive results. We undertook a systematic review and meta-analysis to assess the effects of such treatment on survival and recurrence.
- Chemotherapy for hormone-refractory prostate cancer
Cochrane Systematic Reviews, 2-Jun-2008
Prostate cancer mainly affects elderly men, and its incidence has steadily increased over the last decade. The management of this disease is replete with controversy. In men with advanced, metastatic prostate cancer, hormone therapy is almost universally
- Chemotherapy for malignant germ cell ovarian cancer in adult patients with early stage, advanced and recurrent disease
Cochrane Systematic Reviews, 16-Mar-2011
Malignant germ cell tumour of the ovary occurs in up to 0.07% of woman globally. Due to its rarity, evidence for treatment is lacking and often extrapolates clinical trial results of testicular germ cell cancers. The investigation on this rare tumour is f
- Chemotherapy for metastatic and recurrent cervical cancer
Cochrane Systematic Reviews, 21-Sep-2016
Cervical cancer is the second most common cancer among women up to 65 years of age and is the most frequent cause of death from gynaecological cancers worldwide. A woman's risk of developing cervical cancer by 65 years of age ranges from 0.69% in develope
- Chemotherapy for resistant or recurrent gestational trophoblastic neoplasia
Cochrane Systematic Reviews, 13-Jan-2016
Gestational trophoblastic neoplasia (GTN) is a highly curable group of pregnancy-related tumours; however, approximately 25% of GTN tumours will be resistant to, or will relapse after, initial chemotherapy. These resistant and relapsed lesions will requir
- Chemotherapy for second‐stage Human African trypanosomiasis
Cochrane Systematic Reviews, 28-Jun-2013
Human African trypanosomiasis, or sleeping sickness, is a painful and protracted disease affecting people in the poorest parts of Africa and is fatal without treatment. Few drugs are currently available for second-stage sleeping sickness, with considerabl
